Bailard, Inc. Nkarta, Inc. Transaction History
Bailard, Inc.
- $3.84 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
122Shares Held
66MCall Options Held
120KPut Options Held
40.7K-
Ra Capital Management, L.P. Boston, MA10.8MShares$23.9 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$8.97 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$8.33 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$7.89 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$7.88 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $108M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...